Medical marijuana treatment fundamentally revolves around its primary active compounds: cannabinoids. Among these, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) are the most extensively studied and therapeutically significant. These compounds interact intricately with the body’s endocannabinoid system (ECS), a complex cell-signaling system discovered in the early 1990s. The ECS